Deals
Novartis Sells Blood Unit to Grifols for $1.68 Billion
This article is for subscribers only.
Novartis AG agreed to sell a blood-transfusion diagnostics unit to Spanish health-care company Grifols SA for $1.68 billion as the Swiss drugmaker slims its portfolio.
The transaction, Novartis’s largest asset sale since divesting the Gerber baby food brand in 2007, will probably be completed in the first half of next year, the Basel-based drugmaker said in a statement today.